Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.93
Delayed Data
As of Apr 17
 -0.10 / -3.30%
Today’s Change
1.85
Today|||52-Week Range
4.97
+10.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
AssetsCash52.0M96.8M68.5M45.0M
 
 
 
 
 
Short Term Investment Cash3.5M44.8M-28.3M-22.5M
 
 
 
 
 
Cash & Short Term Investments78.8M112.1M119.3M97.7M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.000.00--
 
InventoriesInventories0.00--------
 
Current AssetsOther Current Assets1.6M2.3M2.9M1.7M
 
 
 
 
 
Current Assets80.4M114.3M122.2M99.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross21.9M21.9M21.4M21.5M
 
 
 
 
 
Depreciation-20.4M-20.6M-20.3M-20.5M
 
 
 
 
 
Other Assets384.0K358.0K331.0K305.0K
 
 
 
 
 
Total Assets82.2M115.9M123.7M100.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.8M5.2M4.4M3.1M
 
 
 
 
 
Short Term Debt9.3M9.2M9.2M9.3M
 
 
 
 
 
Accrued Expenses15.1M15.5M16.5M14.6M
 
 
 
 
 
Other Current Liabilities15.1M15.5M16.5M14.6M
 
 
 
 
 
Other Liabilities32.4M32.7M33.0M30.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt11.6M9.3M7.0M4.7M
 
 
 
 
 
Total Liabilities44.0M41.9M39.9M35.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity38.2M74.0M83.7M65.1M
 
 
 
 
 
Total Shareholder Equity38.2M74.0M83.7M65.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding87.6M101.3M108.9M109.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account